News
FOPE with CIPI team-ups with DCGI to foster dialogue and bolster collaboration with pharma sector: Our Bureau, Bengaluru Monday, August 11, 2025, 13:30 Hrs [IST] Federation of Pha ...
US FDA approves Nyxoah’s Genio system for the treatment of obstructive sleep apnoea: Mont-Saint-Guibert, Belgium Monday, August 11, 2025, 15:00 Hrs [IST] Nyxoah SA, a medical te ...
L V Prasad Eye Institute (LVPEI) is recognized as one of the leading centres globally for corneal neurotization surgery has performed over 40 procedures, achieving surgical success rates comparable to ...
Exports of Ayush and herbal products for the first three months of FY26 has reported a marginal growth of 0.58%, as compared ...
HOPE & NRx Pharma receive final clearance from Florida's AHCA to proceed to closing of Dura Medical acquisition: Miami Monday, August 11, 2025, 13:00 Hrs [IST] HOPE Therapeutics, ...
Clearmind Medicine reports publication of international patent application for novel combination therapy targeting obesity & high blood sugar: Vancouver, Canada Monday, August 11, ...
Aarthi Scans equips its diagnostic services installing Siemens Healthineers’ helium-free 1.5T MRI: Our Bureau, Bengaluru Monday, August 11, 2025, 12:50 Hrs [IST] Aarthi Scans an ...
Global pharma major Lupin Limited (Lupin) announced the launch of glucagon for injection USP, 1mg/vial packaged in an emergency kit in the United States. Glucagon for injection USP, 1mg/vial packaged ...
Zydus receives US FDA final approval for prucalopride tablets, 1 mg & 2 mg: Our Bureau, Mumbai Monday, August 11, 2025, 10:45 Hrs [IST] Zydus Lifesciences Limited has received fin ...
AUTOMA+ 2025 to take place in Vösendorf, Austria from November 24-25: Our Bureau, Mumbai Monday, August 11, 2025, 09:00 Hrs [IST] The Pharmaceutical Automation and Digitalisation ...
Kenya achieves elimination of human African trypanosomiasis or sleeping sickness as a public health problem: Geneva Monday, August 11, 2025, 11:00 Hrs [IST] The World Health Organ ...
Boehringer Ingelheim’s Hernexeos receives US FDA accelerated approval for previously treated patients with HER2-mutant advanced NSCLC: Ingelheim, Germany Monday, August 11, 2025 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results